Is Kambo Safe? A Clear-Eyed Look at Risk, Contraindications, and Why Practitioner Quality Is Everything

"Is Kambo safe?" is one of the most important questions someone can ask before working with this medicine. It deserves a direct, well-grounded answer — not a defensive reassurance, and not a fear-based dismissal. Here is what the evidence actually shows.

The short version: Kambo has a documented safety profile that is broadly favorable when administered with proper screening, appropriate protocols, and qualified facilitation. When those conditions are absent, the risk profile changes significantly. The two situations are not comparable, and collapsing them — treating "Kambo is safe" or "Kambo is dangerous" as universal statements — serves no one.

What the Research Documents

A 2022 systematic review by Sacco et al. analyzed 11 documented cases of acute Kambo intoxication from the preceding decade.¹ The clinical picture across these cases included arrhythmias, dyspnea, nausea, vomiting, diarrhea, abdominal pain, weakness, electrolyte imbalances, psychosis, and seizures. Mechanistically, these events were attributed to peptide-induced autonomic dysregulation, GI hyperstimulation via CCK-A and NK1 receptors, vasodilation and fluid shifts via bradykinin B2 receptors, ADH dysregulation via CRF1 receptor activation, and opioid receptor effects.¹

A broader review in Frontiers in Pharmacology (2022) documented additional pathological conditions associated with Kambo use: acute renal failure, dermatomyositis, esophageal rupture, acute toxic hepatitis, and psychosis.² Most recently, a 2025 case report in the medical literature described a 35-year-old woman who developed severe hyponatremia (plasma sodium of approximately 116 mmol/L), diffuse cerebral edema, and progressed to brain death following a Kambo session.³

These cases are real and must be taken seriously. They are also rare relative to global Kambo use — estimates suggest hundreds of thousands of sessions occur annually worldwide — and virtually all documented serious adverse events involve identifiable, preventable factors: excessive water intake, inadequate screening, inexperienced facilitation, or combination with other substances. The same review literature that documents these events consistently identifies those factors as the primary drivers of harm.

Holistika Center Retreats

The Central Risk: Hyponatremia and SIADH

The most significant documented risk in Kambo sessions is hyponatremia — dangerously low sodium concentration in the blood — and its most serious complication, cerebral edema. This is not simply a matter of "drinking too much water," though excess water intake is a contributing factor. The mechanism is more complex and less widely understood.

Kambo's peptides — specifically via CRF1 receptor activation by sauvagine — can trigger inappropriate secretion of antidiuretic hormone (ADH), causing the kidneys to retain water even when the body is already dilute.^4,5 This condition, called Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), was first documented in a Kambo context by Leban et al. in 2016.⁶ When SIADH is active, even modest fluid intake can precipitate dangerous sodium dilution — independently of how much water a participant drinks.

The brain is enclosed in a rigid skull. When sodium drops and water floods into brain cells through osmosis, intracranial pressure rises rapidly. The consequences — confusion, seizure, coma — can develop within hours of a session. This is the physiological sequence in the 2025 brain-death case: excessive water intake, peptide-induced emesis with sodium loss, and suspected SIADH, creating what the authors called "a perfect storm for acute symptomatic hyponatremia and cerebral herniation."³

Beyond hyponatremia, electrolyte derangements documented in Kambo cases include hypokalemia (low potassium), hypomagnesemia (low magnesium), and hypophosphatemia (low phosphate) — all made worse by the common practice of instructing participants to drink multiple liters of plain water before and during the ceremony.⁷

At Holistika Center, our water protocols are individualized and electrolyte-aware. We do not apply blanket instructions to drink large volumes of plain water. This is not a minor operational detail — it is a clinically significant safety parameter.

Hard Contraindications

There are people for whom Kambo is not appropriate, and any practitioner who tells you otherwise is not practicing safely. The established contraindications include:

Cardiovascular conditions. Kambo causes rapid, significant increases in heart rate and transient blood pressure changes. Anyone with a history of stroke, aneurysm, severe arrhythmia, or unstable blood pressure should not participate. This is non-negotiable.

Pregnancy. Kambo stimulates smooth muscle contraction throughout the body, including the uterine muscle. It is contraindicated at all stages of pregnancy and is traditionally used in some Indigenous contexts specifically to induce abortion.

Active psychiatric conditions. People currently experiencing psychosis, severe bipolar disorder, or recent psychiatric hospitalization should not participate without specialist medical input. Kambo's HPA activation and opioid receptor engagement can destabilize people without a stable nervous system baseline.

Kidney and liver compromise. The metabolic demand of a Kambo session, combined with fluid shifts and peptide-induced vasodilation, places significant burden on both organs. Individuals with known kidney or liver disease require careful medical evaluation before any consideration of participation.

Certain medications. MAOIs, SSRIs, antihypertensives, anticoagulants, and several other pharmaceutical classes interact with Kambo's receptor cascade in potentially dangerous ways. A complete, honest medication disclosure before any ceremony is not optional — it is the minimum.

Readiness Beyond the Medical

Medical clearance is necessary but not sufficient. There are other dimensions of readiness that matter just as much:

If the yes isn't yours, it isn't a yes. Kambo chosen under social pressure — from a partner, a group, a culture, a practitioner — is Kambo entered without full consent of the nervous system. The body knows the difference, and it matters for both the experience and the outcome.

Trust your gut about the practitioner. If your questions aren't being answered clearly, if screening feels rushed or superficial, if the energy feels ungrounded or performative — these are not irrational concerns. They are somatic intelligence. A practitioner's qualifications and groundedness are among the most significant safety variables in the entire system.

Integration is not optional. A Kambo ceremony without adequate time, support, or emotional bandwidth for what follows is a ceremony without its most important half. The weeks after a session are where the recalibration either takes root or gets buried. If your life doesn't have room for that process right now, the timing may simply not be right.

Holistika Center Retreats

Kambo and Ayahuasca in the Same Weekend

One specific combination that warrants careful attention is the increasingly common retreat format that places Kambo and Ayahuasca within 24 to 48 hours of each other. Both medicines significantly alter neurochemistry, both deplete the body, both shift fluid and electrolyte balance. Add a no-salt dieta, repeated purging, high water intake, fasting, and sleep disruption — and the cumulative physiological load becomes a genuine hyponatremia risk factor, independent of either medicine alone.

There are documented hospitalizations associated with back-to-back Kambo and Ayahuasca use. The traditional context for these medicines — where they are practiced separately, by distinct lineages, across different time scales — is not equivalent to the compressed ceremony-tourism format that has evolved in Western retreat culture. Logistical convenience is not the same as physiological wisdom.

What Safe Practice Looks Like

At Holistika Center, every participant completes a thorough health intake before being accepted onto a retreat. We ask about medical history, medications, psychiatric history, previous Kambo and plant medicine experiences, and current life circumstances. We individualize water and electrolyte protocols. We keep groups intentionally small. We provide preparation guidance in the weeks before and integration support in the weeks after.

This is not overcaution. It is the minimum standard for working responsibly with a medicine that acts across multiple organ systems simultaneously, through receptor pathways that are genuinely powerful, with an acute phase that demands both the participant and the practitioner be fully present and well-prepared.

Kambo can be transformative. In the right conditions, with the right person, at the right moment — it often is. Those conditions don't happen by accident.

Ritshi Zenati, Speaker & Life Coach

Founder at Holistika Center.

To learn more about Holistika Center's screening process and upcoming Kambo retreats in Barcelona, Málaga, Mallorca, and across Europe, visit www.holistika.center.

References

1. Sacco, M.A. et al. (2022). Kambo administration and its association with sudden death: clinical and forensic perspectives. Systematic review. Journal of Forensic Sciences.

2. Nogueira, T.A. et al. (2022). The Amazonian kambô frog Phyllomedusa bicolor: current knowledge on biology, phylogeography, toxinology, ethnopharmacology and medical aspects. Frontiers in Pharmacology, 13:997318.

3. Case report (2025). Shamanic Kambô frog hyponatremic toxicity leading to brain death. PubMed, PMID 40502907.

4. Thompson, C. & Williams, M.L. (2022). Review of the physiological effects of Phyllomedusa bicolor skin secretion peptides. SAGE Open Medicine.

5. Campodónico et al. Hyponatremia may be due to central effects of peptides on the nervous system resulting in SIADH. Cited in Sacco et al. (2022).

6. Leban, V., Kozelj, G. & Brvar, M. (2016). The syndrome of inappropriate antidiuretic hormone secretion after giant leaf frog (Phyllomedusa bicolor) venom exposure. Toxicon, 120:107–109.

7. Sacco et al. (2022), op. cit.; Sciencedirect review (2022). Kambo: Natural drug or potential toxic agent? Toxicology Reports.